The Health Ministry has decided to re-examine the quality of two types of medicines following the death of patients reported and various allergies emerged after taking in these medicines.
Ministry Secretary Janaka Sri Chandragupta said that the two types of medicines that have led to complications were received under the Indian credit facility.
The ministry said that a special committee was appointed to investigate the reported cases of patients dying and developing allergies after the use of these two medicines which were registered at the National Medicines Regulatory Authority.
The Ministry Secretary said that the committee is headed by the Director General of Health Services.
He said that the committee will also look into the method of recovering compensation from the pharmaceutical companies for the patients who died after using the medicine and developed allergies.
A woman who was receiving treatment in the intensive care unit of the Peradeniya Hospital died recently after receiving an injection.
Peradeniya Hospital Director Arjuna Tilakaratne said that the patient had been given the anesthetic injection two months ago for a hernia operation.
She was receiving treatment in the intensive care unit in a critical condition.
In addition, Dr. Tilakaratne said that a woman who was admitted for childbirth died after the same anesthetic was administered two months ago.
Meanwhile, the Ministry of Health recently took steps to blacklist ‘Prednisolone’, an eye drop that is used following eye surgery, due to its substandard quality.
